ABOUT
YnnoMed is a drug R&D platform dedicated to addressing the unmet clinical needs of new antimicrobial agents tackling antimicrobial resistance. We have established a cutting-edge antibiotic discovery platform that targets unprecedented drug targets, specifically protein-protein interactions in bacterial RNA synthesis. Our goal is to design, develop, and distribute first-in-class antimicrobial medicines that can treat current antibiotic-resistant bacterial infections, and suppress the generation of new antimicrobial resistance. We also are able to provide drug design and discovery services by using our AI-assisted drug discovery technologies.
Awards and Recognitions
TechConnect 2019
Global Innovation Award
"New Antibiotic Drug Candidates" invented by Dr Cong MA, Assistant Professor, Department of Applied Biology and Chemical Technology, PolyU, and Dr Xiao YANG, Research Assistant Professor, Department of Microbiology, Faculty of Medicine, The Chinese University of Hong Kong
Falling Walls Breakthroughs of the Year 2023 Global Call
Winner, Science Start-ups / Falling Walls Venture
The ONLY company from Hong Kong named as one of 25 Winners in the category of Science Start-ups (Falling Walls Venture) out of 113 Finalists. Participated at Falling Walls Science Summit 2023 and presented at Falling Walls Venture Pitch Day held in Berlin in November 2023.
48th International Exhibition of Inventions Geneva
Exhibitor representing CUHK, Hong Kong delegation
Bronze Medalist
Classe M - Médecine - Chirurgie - Hygiène - Orthopédie - Matériel pour handicapés:
"Série de petites molécules chimiques dont l'efficacité a été prouvée pour éliminer les bactéries pathogènes. Ces molécules antimicrobiennes ont un nouveau mécanisme d'action et un fort potentiel en tant que nouveaux candidats antibiotiques."
CUHK Innovation Day 2022
Champion
"The first Elevator Pitch Competition was also held this year. 13 TSSSU-funded companies competed for four awards, delivering two-minute pitches that introduced their latest research projects. Ynno Med Limited, founded by Professor Yang Xiao, Assistant Professor, Department of Microbiology, Faculty of Medicine won the championship (please see Appendix for the winner list)."
Meet Our Co-Founders
Prof. Xiao Yang
Prof. Yang is a microbiologist with rich experience in the research of bacterial transcription. She identified an RNA polymerase subunit in Bacillus subtilis and the encoding gene was named after her as rpoY.
Prof. Cong Ma
Prof. Ma is dedicated to medicinal chemistry and drug discovery. He leads a team to design and discover a series of first-in-class antimicrobial agents targeting protein-protein interactions in bacterial transcription.
Projects
What makes us special?
